| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
40,010,000 |
| Market
Cap: |
881.42(M) |
| Last
Volume: |
1,008,943 |
Avg
Vol: |
1,006,189 |
| 52
Week Range: |
$12.64 - $30.11 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Cassava Sciences is a clinical-stage biotechnology company. Co. has combined technology with insights in neurobiology to develop solutions for Alzheimer's disease and other neurodegenerative diseases. Co. has two biopharmaceutical assets under development: its primary therapeutic product candidate, called simufilam, is a treatment for Alzheimer's disease; and its primary investigational diagnostic product candidate, called SavaDx, is a way to detect the existence of Alzheimer's disease from a small sample of blood.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
48,477 |
278,477 |
| Total Buy Value |
$0 |
$0 |
$831,428 |
$6,164,449 |
| Total People Bought |
0 |
0 |
2 |
4 |
| Total Buy Transactions |
0 |
0 |
3 |
9 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Friedmann Nadav |
Chief Operating Officer |
• • – |
2011-09-15 |
4 |
S |
$4.89 |
$122,125 |
D/D |
(25,000) |
309,255 |
|
- |
|
| Perry Craig |
10% Owner |
– – • |
2011-08-08 |
4 |
S |
$4.20 |
$186,600 |
D/D |
(44,417) |
4,645,076 |
|
- |
|
| Barbier Remi |
CEO, Chairman of the Board |
• • • |
2011-08-08 |
4 |
B |
$4.22 |
$21,095 |
D/D |
5,000 |
5,948,053 |
3.15 |
- |
|
| Perry Craig |
10% Owner |
– – • |
2011-07-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,689,493 |
|
- |
|
| Friedmann Nadav |
Chief Operating Officer |
• • – |
2011-07-05 |
4 |
A |
$8.75 |
$4,073,254 |
D/D |
452,587 |
334,255 |
|
- |
|
| Friedmann Nadav |
Chief Operating Officer |
• • – |
2011-07-05 |
4 |
OE |
$5.12 |
$3,200,430 |
D/D |
625,084 |
28,530 |
|
- |
|
| Friedmann Nadav |
Chief Operating Officer |
• • – |
2011-06-22 |
4 |
D |
$8.75 |
$1,285,043 |
D/D |
(146,862) |
506,752 |
|
- |
|
| Friedmann Nadav |
Chief Operating Officer |
• • – |
2011-06-22 |
4 |
OE |
$5.12 |
$1,024,000 |
D/D |
200,000 |
653,614 |
|
- |
|
| Friedmann Nadav |
Chief Operating Officer |
• • – |
2011-06-13 |
4 |
D |
$9.12 |
$2,788,212 |
D/D |
(305,725) |
453,614 |
|
- |
|
| Friedmann Nadav |
Chief Operating Officer |
• • – |
2011-06-13 |
4 |
OE |
$5.12 |
$2,176,430 |
D/D |
425,084 |
759,339 |
|
- |
|
| Friedmann Nadav |
Chief Operating Officer |
• • – |
2011-06-01 |
4 |
D |
$10.00 |
$495,570 |
D/D |
(49,557) |
334,255 |
|
- |
|
| Friedmann Nadav |
Chief Operating Officer |
• • – |
2011-06-01 |
4 |
OE |
$5.12 |
$495,565 |
D/D |
96,790 |
383,812 |
|
- |
|
| O Donnell Michael J |
Director |
– • – |
2011-05-13 |
4 |
D |
$9.01 |
$221,808 |
D/D |
(24,618) |
13,968 |
|
- |
|
| O Donnell Michael J |
Director |
– • – |
2011-05-13 |
4 |
OE |
$6.76 |
$221,802 |
D/D |
32,811 |
38,586 |
|
- |
|
| Roddy Peter S |
Chief Financial Officer |
• – – |
2011-05-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,000 |
54,750 |
|
- |
|
| Roddy Peter S |
Chief Financial Officer |
• – – |
2011-05-02 |
4 |
A |
$2.87 |
$14,999 |
D/D |
5,228 |
61,750 |
|
- |
|
| Friedmann Nadav |
Chief Operating Officer |
• • – |
2011-05-02 |
4 |
A |
$2.87 |
$12,500 |
D/D |
4,357 |
287,022 |
|
- |
|
| Robertson Sanford |
Director |
– • – |
2011-03-29 |
4 |
OE |
$6.76 |
$221,802 |
D/D |
32,811 |
276,830 |
|
- |
|
| Barbier Remi |
CEO & Chairman of the Board |
• • • |
2011-03-14 |
4 |
D |
$6.10 |
$8,467 |
D/D |
(1,388) |
5,943,053 |
|
- |
|
| Barbier Remi |
CEO & Chairman of the Board |
• • • |
2011-03-14 |
4 |
OE |
$6.10 |
$12,005 |
D/D |
1,968 |
5,944,441 |
|
- |
|
| Barbier Remi |
CEO & Chairman of the Board |
• • • |
2011-03-04 |
4 |
GA |
$0.00 |
$0 |
I/I |
7,600 |
55,975 |
|
- |
|
| Barbier Remi |
CEO & Chairman of the Board |
• • • |
2011-03-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,900 |
5,942,473 |
|
- |
|
| Schoenhard Grant |
Director |
– • – |
2011-02-28 |
4 |
D |
$6.84 |
$412,315 |
D/D |
(60,280) |
55,499 |
|
- |
|
| Schoenhard Grant |
Director |
– • – |
2011-02-28 |
4 |
OE |
$6.10 |
$412,311 |
D/D |
67,592 |
115,779 |
|
- |
|
| Roddy Peter S |
Chief Financial Officer |
• – – |
2010-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
12,465 |
56,522 |
|
- |
|
504 Records found
|
|
Page 6 of 21 |
|
|
0.42 (1.87%) 
